Leanne Embree
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
Papers in ⓘ
-
- Analytical Methods in Pharmaceuticals 4
-
- Antibiotics Pharmacokinetics and Efficacy 3
- Co-authors
- Philip M. Toleikis (1 shared paper)Helen M. Burt (1 shared paper)William L. Hunter (1 shared paper)Xichen Zhang (1 shared paper)Norma J. Hudon (5 shared papers)Karen A. Gelmon (4 shared papers)Marcel B. Bally (3 shared papers)Keith M. McErlane (3 shared papers)
- Journals
- Journal of Pharmaceutical and Biomedical Analysis (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Pharmaceutical Sciences (1 paper)Journal of Clinical Oncology (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)
- Partner nations
- CanadaUnited States
In The Last Decade
Leanne Embree
15 papers receiving 540 citations
Peers
Comparison fields: 5 of 74
- Biomaterials 243
- Pharmaceutical Science 63
- Oncology 155
- Hematology 61
- Analytical Chemistry 41
Countries citing papers authored by Leanne Embree
This map shows the geographic impact of Leanne Embree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leanne Embree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leanne Embree more than expected).
Fields of papers citing papers by Leanne Embree
This network shows the impact of papers produced by Leanne Embree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leanne Embree. The network helps show where Leanne Embree may publish in the future.
Co-authors
The 25 scholars most cited alongside Leanne Embree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 202 | |
| 2 | 1999 | 91 | |
| 3 | 1998 | 39 | |
| 4 | 1993 | 34 | |
| 5 | 1997 | 34 | |
| 6 | 1997 | 28 | |
| 7 | 1993 | 25 | |
| 8 | 1999 | 24 | |
| 9 | 1996 | 23 | |
| 10 | 1995 | 19 | |
| 11 | 1989 | 14 | |
| 12 | 2000 | 12 | |
| 13 | 1990 | 5 | |
| 14 | 1990 | 4 | |
| 15 | Comparison of analysis of digoxin in cardiac patients by HPLC and RIA. | 1990 | 3 |
About Leanne Embree
Leanne Embree is a scholar working on Analytical Chemistry, Pharmacology, Oncology, Hematology and Bioengineering, having authored 15 papers that have together received 557 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (4 papers), Cancer Treatment and Pharmacology (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Chemotherapy-induced organ toxicity mitigation (3 papers), Analytical Chemistry and Chromatography (2 papers), Lanthanide and Transition Metal Complexes (2 papers), Corneal Surgery and Treatments (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). The work is most often cited by research in Biomaterials (243 citations), Pharmaceutical Science (63 citations), Oncology (155 citations), Hematology (61 citations) and Analytical Chemistry (41 citations). Leanne Embree has collaborated with scholars based in Canada and United States. Frequent co-authors include Philip M. Toleikis, Helen M. Burt, William L. Hunter, Xichen Zhang, Norma J. Hudon, Karen A. Gelmon, Marcel B. Bally, Keith M. McErlane, Lawrence D. Mayer and B. Melosky. Their work appears in journals such as Journal of Pharmaceutical and Biomedical Analysis, Cancer Chemotherapy and Pharmacology, Journal of Pharmaceutical Sciences, Journal of Clinical Oncology and Colloids and Surfaces B Biointerfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.